Document KJY4voqJmdmYrzdzrqwxnx006
r 3M General Offices
AR226-1897
3M Center St. Paul. MN 55144-1000 651 733 1110
Mi^ A
3M
September 24, 20Q& SI"
By Hand Delivery
169p.
Document Processing Center (7407) Office of Pollution, Prevention and Toxics U.S. Environmental Protection Agency 1200 Pennsylvania Avenue, N. W. Washington, DC 20460 Attention: Section 8(e) Coordinator
Re: TSCA Section 8(e) Submissions
Dear Sir/Madam:
3M Company ("3M") requests that EPA place the attached studies in the TSCA Section 8(e) docket. W e have included a master index for these studies identifying the study title, test substance and CAS number. A Confidential Business Information (CBI) version of this index and the studies also is being submitted today pursuant to EPA procedures. 3M has not provided CBI substantiation with this submission, but would be willing to do so at the Agency's request.
3M has concluded that data in these studies may not be, strictly speaking, "corroborative" of previously reported or published information as defined in EPA's reporting guidance or otherwise potentially may warrant 8(e) submission based on EPA's reporting guidance.
3M appreciates EPA's attention to this matter. Please contact the undersigned if you have any questions or require further information regarding this submission.
Very truly yours,
llllliilllHIIIliilllllllllllillllll!
8 EHQ - 0 4
i 584 S
f\ld L iA ,u K ^ . f a L i0[
Dr. Katherine E. Reed, Ph.D
C=;>
Staff Vice President
^r n
Environmental Technology and Safety j h f f l
Services
o
(651)778-4331
kereed@mmm.com
88040000367
880
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
Primary Eye Irritation Study -
Rabbits
l 3l 20% solids (Ethomeen S/12 1.0M with diethyl
3
sulfate 0.94M); 80% water [Ethomeen S/12 = R-
Guinea Pig Contact Dermal
N(Et)+(C2H40H)2 where R=C18 with 1-2
Irritation/Sensitization
double bondsl
20% (61791-24-0 with 64-67-5); 80% 7732-18-5
Primary Eye Irritation Study -
Rabbits
Butanoic acid, heptafluoro-, calcium salt
2366-98-5
Acute Oral Toxicity Screen with T-
2712CoC in Albino Rabbits
perfluorohexanoic acid
307-24-4
Primary Skin Irritation Test with T-
2725Ec (Repeat Application) in
Albino Rabbits
l
Acute Ocular Irritation Test with T-
3t
3
2725Ec in Albino Rabbits
[
Sensitization Study with T-2741AC
3l
3
in Albino Guinea Pigs
t
3t
Oral Rangefinder Study of T-3140BS 1-[3'-(perfluorooctanesu!fonate) anilino amide]-2
3
in Pregnant Rats
potassium 3,4,5,6-tetrachlorophthalate 80% 1-[3'-(perfluorooctanesulfonate) anilino
57589-85-2
amide]-2-potassium 3,4,5,6-
Oral Rangefinder Study of T-3139BS tetrachlorophthalate; 5% C7 homolog; 5% C5 80% 57589-85-2; 5% 68541-01-5 ; 5% 68541-02-6;
in Pregnant Rats
homolog; 5% C4 homolog; 5% C6 homolog
5% 68568-54-7; 5% 68815-72-5
Acute Occular Irritation Test with T- perfluoroethylcyclohexylsulfonic acid diethanol
2997CoC in Albino Rabbits
amine salt
salt of 133201-07-7 and 111-42-2
Sensitization Study with T-3386 in
Albino Guinea Pigs
[
In Vitro Microbiological Mutagenicity
1[
3
Assays of 3M Company's
Compound T-3411
I_________________________________ )______ 1_________________________________ 1
1
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
68% poly(oxy-1,2-ethanediyl), alpha-[2-
[ethyl[(heptanedecafluorooctyl)sulfonyljamino]et
hylj-omega-hydroxy-; 12% polethylene glycol;
7% water; 4.86% poly(oxy-1.2-ethanediyl),
alpha-[2-
[ethyl[{pentadecafluoroheptyl)sulfonyl]amino]eth
yl]-omega-hydroxy-; 4% residual organic
fluorochemical; 3% heptadecafluoro-1-
octanesulfonic acid; 0.81% poly(oxy-1,2-
ethanediyl), alpha-[2-
[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl]-
omega-hydroxy-; 0.3% 1,4-dioxane; 0.2% n- 68% 29117-08-6; 12% 25322-68-3; 7% 7732-18-5;
ethylperfluorooctanesulfonamidoethyl alcohol; 4.86% 56372-23-7; 4.05% 68298-79-3; 3.24%
Acute Oral Toxicity Screen with T- 0.03% linear n-ethyl
68298-81-7; 3% 1763-23-1; 0.81% 68298-80-6;
3448 in Albino Rats
perfluorooctanesulfonamide
0.3% 123-91-1; 0.2% 1691-99-2; 0.03% 4151-50-2
]n Vitro Microbiological Mutagenicity
Assays of 3M 0 0 0 1 (3 3 0 /8
Compound T-3516
l ............
Acute Dermal Toxicity Study with T-
_.
I [ ............
I
3451 in Albino Rabbits
C 8 F 1 7S 0 2N (C H 3).N a
Unknown
Acute Oral Toxicity - Method,
Summary, Pathology; Primary
Dermal Irritation - Method,
Summary; Primary Eye Irritation -
Method. Summary; Guinea Pig
Maximization - Method, Summary i
Acute Oral Toxicity - Method,
] [_ _
]
Summary, Pathology; Primary
Dermal Irritation - Method,
Summary; Primary Eye Irritation -
Method, Summary;
[
I .[
I
Dermal Sensitization Study in
[
lt
1
Guinea Pigs, Maximization Test -
Method, Summary 4 Hour Acute Aerosol Inhalation
[ t
l I ........ ] I_
I 1
Toxicity Study with T-3825 in Rats t Primary Eye Irritaiton/Corrosion
1l
]
Study in Rabbits 4-Hour Acute Aerosol Inhalation
[
1I
]
Toxicity Study with T-3825 in Rats I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 1_ _ _ _ I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 1_ _ _ _ _ _ _
2
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
T-3820: Acule Inhalation Toxicity
T-3821: Acute Inhalation Toxicity Test T-3845 Acute Inhalation Toxicity Test Evaluation of the Acute Inhalation Toxicity of T-3920 in the Rat Primary Eye Irritation Study in Rabbits - Method, Summary Acute Oral Toxicity Study in Rats (OECD Guidelines) Acute Inhalation Toxicity Study with T-4129 in the Rat Acute Inhalation Toxicity Study with T-4130in theR at Acute Oral Toxicity Study in Rats; Acute Dermal Irritation Study in Rabbits; Acute Eye Irritation Study in Rabbits Dermal Sensitization Study in Guinea Pigs - Maximization Test
I heptafluorobutyryl chloride
..........I .
I ...............................3..............Decanoic acid, nonadecafluoro-, ammonium
salt 95% ammonium perfluorodecanoate; 5%
ammonium periluorooctanoate
[
.............................
] .........
i3
(3 [1
t 375-16-6 (. 3108-42-7 5% 3825-26-1 ( L
l l
...........................
1 3
3 3 3 1
.
Mutagenicity Test on T- 4413 { J
Mouse Lymphoma Forward Mutation
Assay with Duplicate Cultures
3
Acute Inhalation Toxicity Study with
1t
1
T-4354 in the Rat
l
Primary Dermal Irritation/Corrosion
3 [_
1
Study in Rabbits Acute Inhalation Toxicity Study in
t
1[
1
the Rat with T-4397 Primary Eye Irritation/Corrosion
[
1l
1
Study of T-5261 in Rabbits
lithium tetrafluoroethane-1,2-disulfonimide
Unknown
Acute Inhalation Toxicity Evaluation
on T-5231 in Rats 4-Hour, Acute Inhalation Toxicity
t
3l
3
Study with T-5305 in Rats 4-Hour, Acute Inhalation Toxicity
I
3 [......
3
Study (Limit Test) with T-5343.1 in
Rats
I_________________________________ l______ I _________________________________ ]_________
N3
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
4-Hour, Acute Inhalation Toxicity
Study With T-5306 in Rats 4-Hour, Acute Inhalation Toxicity
[
1[
3
Study (Limit Test) with T-5357.1 Acute Dermal Toxicity Study of T-
l
1 ... [
3
4201 in Rabbits
Lithium Bis(Trifluoromethanesulfonyl)imide
90076-65-6
SubAcute 28-Day Oral Toxicity with
T-2816 by Daily Gavage in the Rat
Followed by a 14 Day Recovery
Period
1
Subacute 28-Day Oral Toxicity with
11
1
T-2816 by Daily Gavage in the Rat
Followed by a 14-Day Recovery
Period
[
Acute Inhalation Toxicity Evaluation
1l
3
on T-5187 in Rats
f
T-4240 4-W eek Oral Toxicity Study
`
33
3
in Rats Dermal Sensitization Study of T-
t
1i
1
5473 in Guinea Pigs - Maximization
Test 4-Hour. Acute Inhalation Toxicity
l
11
3
Study With T-5698 in Rats
[
Acute Inhalation Toxicity Evaluation
1l
3
On T-5708 in Rats T-5486 Assessment of Cardiac
r
11
3
Sensitization Potential in Dogs
octafluoropropane
76-19-7
Acute inhalation Toxicity Evaluation
on T-5655 in Rats
[ ...
T-4201 4 W eek Oral Toxicity Study
] [ ......
3
in Rats with 2-W eek Recovery
Period
Lithium BisfTrifluoromethanesulfonyl)imide
90076-65-6
T-5658: Eye Irritation to the Rabbit t
Acute Inhalation Toxicity Evaluation
1i
1
onT-5715in Rats
t
Acute Inhalation Toxicity Evaluation
3l
3
on T-5716 in Rats
f
Acute Inhalation Toxicity Study of T-
3f
3
5724 in Rats
[
3t
1
Acute Inhalation Toxicity Study of T-
5725 (Resin Solution) in Rats
]I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 3_ _ _ _ J i_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 3
4
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
Acute Inhalation Toxicity Study
(Limit Test) of T-5927 in Rats
1
Acute Inhalation Toxicity Study of T-
5928 in Rats (LC50)
i
Acute Inhalation Toxicity Evaluation
on T-5829 in Rats Single-Dose Intravenous
[
Pharmacokinetic Study of T-5963 in
Rabbits Single-Dose Intravenous
I
Pharmacokinetic Study of T-6030 in
Rabbits
i
. . . -.... -.......... I .....................................................I
1
............................... - .
I
............................................ 1
I I l.
[
L_ .
] ] I
]
]
87-93% fluorinated alkyl alkoxylates; 4-10%
linear N-ethyl perfiuorooctanesulfonamide; 2-
4% poly(oxy-1,2-ethanediyl),.alpha.-[2-
[ethyl[(pentadecafluoroheptyl)sulfonyl]aminojeth
yl]-.omega.-methoxy-; 0-4% residual organic
fluorochemicals; 0-2% c8 sulfonamide; 0.1-1%
5-Daily Dose Dermal
1-heptanesulfonamide, N-ethyl-
Absorption/Toxicity Study of T-6029 1,1,2,2.3,3,4,4.5,5,6.6,7.7,7-pentadecafluoro-; 87-93% 68958-61-2; 4-10% 4151-50-2; 2-4%
and T-6032 in Rabbits
miscellaneous components (each less than 1%) 68958-60-1; 0-2% 31506-32-8; 0.1-1% 68957-62-0
Single-Dose Intravenous
Pharmacokinetic Study of T-6061 in
Rabbits Single-Dose Intravenous
[
1 t.
]
Pharmacokinetic Study of T-6065 in
Rabbits Single Dose Intravenous
[ ......................................... ... 1 . f
1
Pharmacokinetic Study of T-6063 in
Rabbits
[
Acute Inhalation Toxicity Study of T-
]t
..................... 1
6235 in Rats
1
Primary Dermal Irritalion/Corrosion
................................... ... 1 _. t
]
Study of T-6402 in Rabbits
[
1l
]
Dermal Sensitization Study of T-
6402 in Guinea Pigs- Maximization
Test (EC Guidelines)
t
]
Acute Eye Irritation/Corrosion Study 1-Butanesulfinic acid, 1.1,2.2.3,3,4,4,4-
with T-6318 in the Rabbit
nonafluoro-. Sodium Salt
[ ... _ 102061-82-5
I
5
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
Primary Skin Irritation / Corrosion
Study with T-6567 in the Rabbit (4-
Hour Semi-Occlusive Application) t Assessment of Contact
1
Hypersenitivity to T-6318 in the
Albino Guinea Pig (Maximization 1-Butanesulfinic acid, 1,1,2,2,3,3,4,4,4-
Test)
nonafluoro-, Sodium Salt
Single-Dose Intravenous
Pharmacokinetic Study of T-6502 in
Rabbits Single-Dose Intravenous
[
]
Pharmacokinetic Study of T-6504 in
Rabbits Single Dose Intravenous
t
]
Pharmacokinetic Study of T-6506 in
Rabbits
i
A Study for Effect on Embryofoeta!
1
Development of the Rat (Inhalation 20-80% methyl nonafluoroisobutyl ether; 20-
Administration)
80% methyl nonfluorobutylether
Bacterial Reverse Mutation Test of T
6695
l
]
5-day Inhalation Toxicity of
Perfluorocyclohexene ([ ]; T-
70% crude perfluorocyclohexene; 30%
6878) in Rats
perfluoromethylcyclopentene
5-Daily Dose Dermal
Absorption/Toxicity Study of T-6502
and T-6503 in Rabbits Primary Eye Irritation/Corrosion
[
I
Study of T-6786 in Rabbits
Lithium Bis(perfluoroethylsulfonyl)imide
Primary Dermal Irritation/Corrosion
Study of T-6804 in Rabbits
Lithium Bis(perfluoroethylsuifonyi)imide
5-Day Inhalation Toxicity Screen of
HFE( 1
C-C6F110CH3
Primary Eye Irritation/Corrosion
Study of T-6804 in a Rabbit (OECD
Guidelines)
Lithium Bis(perfluoroethyisulfonyl)imide
Acute Oral Toxicity Study of T-6804
in Rats (OECD Guidelines)
Lithium Bis(perfluoroethylsulfonyl)imide
Dermal Sensitization Study of T6908 in Guinea Pigs, Mazimizatton Test (EC Guidelines)
102061-82-5
i
.................
I
l _J
[ ]. 20-80% 163702-08-7; 20-80% 163702-07-6 [] 70% 355-75-9
[ 132843-44-8 132843-44-8 4943-08-2
1
132843-44-8 132843-44-8
6
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
Eye Irritation/Corrosion Study of T- N-Me Fos Amide-Triphenylbenzyl Phosphonium
4127 in the Rabbit
Chloride Complex; D-1624
31506-32-8
Single-Dose Intravenous
Pharmacokinetic Study of T-6924 in
Rabbits
[
J[
1
Derma! Sensitization Study of T6924 in Guinea Pigs- Maximization Test (EC Guidelines)
r
]t
I
Dermal Sensitization Study of T-
7003 in Guinea Pigs - Maximization
Test (EC Guidelines)
[
Report of Sera and Liver Data for [ N-ethyl heptadecafiuoro-N[2-
J
] Monoester - Preliminary ADME (phosphonooxy)ethyl) octanesulfonamide
Study in Rats
diammonium salt
[ ) Diester-Pharmacokinetic
Study in Rats (Study No. T-7043.1, ammonium
DT-26)
bisfethyl(perfluorooctane)sulfonayl]phosphate
Single Dose Intravenous
Pharmacokinetic Study with T-7082
in Rabbits
i ...................... N-ethyl heptadecafluoro-N[2-
j
[ ] Monoester - Pharmacokinetic (phosphonooxy)ethyl] octanesulfonamide
Study in Rats (Study No. T-6997.2) diammonium salt
Determination of PFOS Presence
and Concentration in Serum from
the Dermal Absorption Studies of T-
7106 and T-7107 in Hra:(NZW)SPF
Rabbits Dermal Sensitization Study of T-
t
I
7285.5 in Guinea Pigs -
Maximization Test (EPA/OECD
Guidelines)
l
Twenty-eight Day Repeated-Dose
J
Oral Toxicity Study of T-6861 in
Rats
Lithium Bis(perfluoroethylsulfonyl)imide
Twenty-eight Day Repeated Dose
Oral Toxicity Study of T-7005 in
Rats
I _________________________________ 1
t 67969-69-1 30381-98-7 I ... 67969-69-1
I 1
I _ ...................
]
I_ 132843-44-8
I
1_________________________________ 1_________
7
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
Acute (4-Hour) Inhalation Toxicity of
Test Atmospheres Obtained after
Heating {
] in Rats I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ J
Toxicokinetic Study of
Perflurooctanesulfonamidoacetate ([
]; T-7071.2) in Rats
perfluorooctanesulfonamido carboxylic acid
[ ..................................
2806-24-8
J
Acute Nose-Only Inhalation Toxicity
Study of T-7087, T-7088, T-7089
and T-7090 in Rats (Limit Test) i _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 11_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ L
Acute Ocular Irritation Study of T-
7485 Applied to New Zealand White
Rabbits
potassium nonafluorobutanesulfonate
Toxicokinetic Study of
Perfluorooctane Sulfonamide
(PFOSA; T-7132.2) in Rats
perfluorooctanesulfonamide
Acute Four-Hour Inhalation Study in Perflurobutanesulfonyl Fluoride (96-98% ) And
Rats
Perfluorosulfolane (2-4% )
Primary Eye Irritation/Corrosion
Study of T-7508.2 in Rabbits MV31 K-Salz; Test for Primary
[
........................ J
Dermal Irritation in the Rabbit
[
Assessment of Acute Oral Toxicity
........................1 .
with T-7560 In The Rat (Acute Toxic
Class Method)
1
Acute Eye Irritation/Corrosion Study
.... J
with T-7560 in the Rabbit
( ] Potassium bis-
l
1
(perfluorobutanesulfonyl)imide
Repeat Dose ADME Study in Rats Potassium bis(perfluorobutanesulfonyl)imide
Toxicity Study by Repeat Dose
Inhalation Administration to CD Rats Perflurobutanesulfonyl Fluoride (96-98% ) And
for 4 Weeks
Perfluorosulfolane (2-4% )
{ l
29420-49-3
754-91-6 96-98% 375-72-4; 2-4% 42060-64-0
I [
[_ 1.
...
129135-87-1
96-98% 375-72-4; 2-4% 42060-64-0
] 1
1 1 ] I
A Sub-acute( 28 Day) Inhalation
Toxicity Study, Including a Recovery 1,1,1,2,2,4,5.5,5-nonafiuoro-4-(trifluoromethyl)-3
Study, with.T-7479 in Rats
pentanon
756-13-8
Xenochemical Receptor trans-
Activation by Perfluorooctane-based
Chemicals
perfluorooctanesulfonamide
754-91-6
8
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
84% 1-octanesutfonic acid,
1.1.2,2.3,3,4,4,5,5,6,6.7,7,8,8,8-
heptadecafluoro-, potassium salt: 5.5%
potassium (perfluorohexyl)sulfonate; 4%
potassium nonafluorobutanesulfonate; 4%
potassium perfluoroheptanesulfonate; 2%
potassium perfluoropentanesulfanate; 0.5%
84% 2795-39-3; 5.5% 3871-99-6; 4% 29420-49-3;
unknown
4% 60270-55-5; 2% 3872-25-1
95% N-ethylperfluorooctanesulfonamidoethyl
alcohol: 5% 1-heptanesulfonamide N-ethyl-
1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-
(2-hydroxyethyl)-
95% 1691-99-2; 5% 68555-73-7
Acute Inhalation ToxicoKinetic Study
of Perfluoroctanesutfonyl Fluroide
(POSF) T-7098.4
perfluorooctanesulfonyl fluoride
307-35-7
Five-Day Inhalation Toxicity Study of
HFE [ ] in Male CD Rats
C-C6F11-CF2-0-CH3
181214-67-5
Acute Toxicity Screen of
Perfluorocyclohexene (T-6878) in 70% crude perfluorocyclohexene; 30%
Rats
perfluoromethylcyclopentene
70% 355-75-9
[ ] (T-7056)
Toxicokinetic Study in Rats
ll_________________________________ I
I
N-Methyl Perfluorobutylsulfonamide = 95% 1-
1
Assessment of Acute Oral Toxicity Butanesulfonamide, 1,1,2,2,3,3,4,4,4-
with T-7601.3 in the Rat (Acute
Nonafluoro-n-Methyl; 5% N-Methyt-4-Hydrido-
Toxic Class Method)
Perfluorobutylsulfonamide
68298-12-4
Subchronic 90-Day Oral Toxicity
Study with T-7320 By Daily Gavage
in the Rat Followed by a 28-Day
Recovery Period
l
1[
1
84% 1-octanesulfonicacid,
Protein Binding of Perfluorobutane 1,1,2,2,3,3,4,4,5,5,6,6,7,7.8,8,8-
Sulfonate, Perfluorohexane
heptadecafluoro-, potassium salt; 5.5%
Sulfonate, Perfluorooctane Sulfonate potassium (perfluorohexyl)sulfonate; 4%
and Perfluorooctanoate to Plasma potassium nonafluorobutanesulfonate; 4%
(Human, Rat, and Monkey), and potassium perfluoroheptanesulfonate; 2%
Various Human-Derived Plasma potassium perfluoropentanesulfanate; 0.5%
Protein Fractions
unknown
potassium nonafluorobutanesulfonate
potassium (perfluorohexyl)sulfonate
84% 2795-39-3; 5.5% 3871-99-6; 4% 29420-49-3; 4% 60270-55-5; 2% 3872-25-1 29420-49-3 3871-99-6
9
Master Index to Studies Submitted Under TSCA 8(e) by 3M Company on September 24, 2004 (Confidential Business Information Redacted)
potassium perfluorooctanoate
Five Day Inhalation Toxicity Study of
[ ] Monochloride. [ ], and
HCFC225cb in Male CD Rats
C4F9-OCH2CI
C-C6F11-CF2-0-CH3
CF2CICF2CHCIF
Toxlcoklnetic Screen of [
] (T-
7483) in Rats
C 7 F 1 5C {0)N (H )C H 3
84% 1-octanesulfonic add,
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
heptadecafluoro-, potassium salt; 5.5%
potassium (perfluorohexylsulfonate; 4%
Low Level Oral
potassium nonahuorobtanesulfonate; 4%
Perfluorooctanesulfonate (PFOS) potassium perfluoroheptanesulfonate; 2%
DoseToxicokinetic Study in Rats: potassium perfluoropentanesulfanate; 0.5%
Serum and Liver PFOS
unknown
2395-00-8 205367-42-6 (n-isomer) and 221617-86-3 (Iisomer) 181214-67-5 507-55-1 89685-56-3
84% 2795-39-3; 5.5% 3871-99-6; 4% 29420-49-3; 4% 60270-55-5; 2% 3872-25-1
10
